Cargando…
Inhibition of dopamine receptor D1 signaling promotes human bile duct cancer progression via WNT signaling
Bile duct cancer (BDC) frequently invades the nerve fibers, making complete surgical resection difficult. A single tumor mass contains cells of variable malignancy and cell‐differentiation states, with cancer stem cells (CSCs) considered responsible for poor clinical outcomes. This study aimed to in...
Autores principales: | Yogo, Akitada, Masui, Toshihiko, Takaishi, Shigeo, Masuo, Kenji, Chen, Ru, Kasai, Yosuke, Nagai, Kazuyuki, Anazawa, Takayuki, Watanabe, Sadanori, Sakamoto, Satoko, Watanabe, Akira, Inagaki, Ryosaku, Nakagawa, Masahiro M., Ogawa, Seishi, Seno, Hiroshi, Uemoto, Shinji, Hatano, Etsuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067401/ https://www.ncbi.nlm.nih.gov/pubmed/36441110 http://dx.doi.org/10.1111/cas.15676 |
Ejemplares similares
-
Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer
por: Watanabe, Sadanori, et al.
Publicado: (2022) -
SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2
por: Masuo, Kenji, et al.
Publicado: (2021) -
Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity‐modulated radiotherapy for resectable pancreatic cancer: A prospective, open‐label, phase II study
por: Masui, Toshihiko, et al.
Publicado: (2023) -
Time–frequency analysis of serum with proton nuclear magnetic resonance for diagnosis of pancreatic cancer
por: Sato, Asahi, et al.
Publicado: (2020) -
Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase II study in a single institution
por: Masui, Toshihiko, et al.
Publicado: (2022)